This presentation, sponsored by Pierrel Pharma, a global leader in quality dental anesthetics, will introduce you to Orabloc®, an aseptically produced articaine anesthetic that clearly differentiates itself from all other local anesthetics on the market. Successfully used by clinicians for years throughout Europe, Orabloc® is now approved by the FDA for use in the U.S.
Orabloc® delivers a rapid onset time of one to nine minutes and a reliable duration of up to one hour. It has a 33% longer shelf life, less epinephrine overages than anesthetic made with a terminal sterilization process, and requires less volume than lidocaine anesthetics.
Click the arrow to view the training material.
Desktop and Mobile Compatible
You must be logged in to take notes for this class.